Andrew Percy

Andrew Percy, PhD, is a seasoned chemist specializing in mass spectrometry and bioanalytical chemistry. Currently serving as a Senior Applications Chemist at Cambridge Isotope Laboratories, Inc. since February 2016, Andrew applies expertise in 'omics and newborn screening to assist with product development and market analysis. Previously, Andrew led the Quantitative Proteomics Group at UVic-Genome BC Proteomics Centre, where contributions included enhancing methodologies for protein biomarker quantification and developing quality control assays. Initial research endeavors at the University of Calgary included advanced studies in H/DX-MS and analytical methods for various chemical species, culminating in a PhD in Bioanalytical Chemistry. Andrew holds an MSc in Analytical Chemistry and a BSc in Chemistry, both from the University of Calgary.